In November, McDermott Will & Emery was pleased to host our annual European Health & Life Sciences Symposium in Paris. Welcoming a large crowd of healthcare professionals, investors and dealmakers for a programme of...more
1/22/2024
/ Algorithms ,
Artificial Intelligence ,
Big Data ,
EU ,
Health Information Technologies ,
Healthcare ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Privacy Laws ,
Technology Sector
200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
A year ago, many stakeholders were apprehensive about the economic consequences of the COVID-19 health crisis, and no one knew whether it would affect private equity permanently. Despite the long-term crisis, activity in...more
9/1/2021
/ Capital Markets ,
Coronavirus/COVID-19 ,
Corporate Social Responsibility ,
Equity Markets ,
EU ,
France ,
Investment ,
Investors ,
Private Equity ,
Recovery Plans ,
Sustainability
After a year during which uncertainty in the equity markets became the new normal, many stakeholders are wondering whether the disruptions are behind us. A look at key indicators might lead one to say yes. The S&P Loan Index...more
8/4/2021
/ Borrowers ,
Coronavirus/COVID-19 ,
Environmental Social & Governance (ESG) ,
Equity Markets ,
EU ,
European Banking Authority (EBA) ,
Financial Services Industry ,
Financial Stimulus ,
Healthcare ,
Liquidity ,
UK